Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis / 中西医结合学报
Journal of Integrative Medicine
;
(12): 147-155, 2014.
Article
Dans Anglais
| WPRIM
| ID: wpr-308201
ABSTRACT
Liver fibrosis is a primary cause of liver cirrhosis, and even hepatocarcinoma. Recently, the usage of mesenchymal stem cells (MSCs) has been investigated to improve liver fibrosis. It has been reported that the differentiation, proliferation and migration of MSCs can be regulated by traditional Chinese medicine treatment; however, the mechanisms are still unclear. In this article, the authors review the characteristics of MSCs such as multidirectional differentiation and homing, and its application in animal experiments and clinical trials. The authors also list areas that need further investigation, andlook at the future prospects of clinical application of MSCs.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Physiologie
/
Thérapeutique
/
Différenciation cellulaire
/
Mouvement cellulaire
/
Essais cliniques comme sujet
/
Association thérapeutique
/
Biologie cellulaire
/
Transplantation de cellules souches mésenchymateuses
/
Cellules souches mésenchymateuses
/
Cirrhose du foie
Type d'étude:
Etude diagnostique
Limites du sujet:
Animaux
/
Humains
langue:
Anglais
Texte intégral:
Journal of Integrative Medicine
Année:
2014
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS